proteolysis inducing factor receptor antagonists (Halsa Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameproteolysis inducing factor receptor antagonists (Halsa Pharmaceuticals)
Drug Alias NamePIFR antagonists (Halsa Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCachexia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAston University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCachexia

Other Information

ATC CodeN/A
Related LinksN/A